Sanofi US

Sanofi US

Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme.

Sanofi US has headquarters in Bridgewater, New Jersey.  Our affiliate companies in the United States include Genzyme (rare diseases), Sanofi Pasteur (vaccines), Merial (animal health) and Chattem (consumer healthcare).

At Sanofi, patients and their needs are at the heart of what we do.

Videos From This Campaign

Content from this campaign

Sanofi and Michael J. Fox Foundation Collaborate on Potential New Treatment for Parkinson’s Disease
(3BL Media) April 19, 2012 - Sanofi announced today that it has entered into a collaboration with the Michael J. Fox Foundation (MJFF) to conduct a clinical trial to assess the safety and tolerability of AVE 8112, a Sanofi PDE4 inhibitor – phosphodiesterase type 4 inhibitor - in patients with Parkinson’s disease (PD).   “AVE8112 has shown promising pro-cognitive...
Apr 19, 2012 4:00 PM ET
Sanofi US Launches 2012 Data Design Diabetes Innovation Challenge
(3BL Media / theCSRfeed) Bridgewater, NJ - March 2, 2012 - Sanofi US announced that it is accepting entries for the Data Design Diabetes™ Innovation Challenge. The Innovation Challenge is aligned with the United States government's initiative to use an open dialogue to drive action toward a three-part aim: innovation in the...
Mar 2, 2012 5:00 AM ET

Pages